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Transport systems analogous m the T and L carriers for aromatic and bulky dipolar amino acids in plasma membranes 
have been characterized in the membranes of intact lysosomes isolated from human fetal skin fibroblasts. While system 
L appears ubiquitous in plasma membranes, system T has previously been discriminated only in the plasmalemma of 
human red Mood cells aml |resi'dy isolated rat helmtOcytes, Our findings with the iysosomal systems, provisionally 
designated t and I, reveal both shared and dissimilar properties with the plasma membrane systems. These properties 
include a lack of dependency on extralysosomal Na ÷, differential sensitivities to the classical system L analog, 
2-aminobicydol2.2.1lheptane-2-cm'boxylic acid (BCH), and the system T analog, D.tryptophan, as well as susceptibility 
to thiol modification at the membrane by reactivity with N-ethylmaleimide. A transport system in lysosomes from the 
FRTL-5 rat thyroid cell line has been described by Bernar et al. ((1986) J. Biol. Chem. 261, 17107-17112) resembles a 
composite of both carrier systems reported in this work. 
Introduction 
Evidence that the transport of bulky, dipolar ( 'neu- 
tral') amino acids across plasma membranes is heteroge- 
neous in nature has been reported for human red blood 
cells [2-4], for isolated rat hepatocytes [5] and for 
freshly isolated versus primary culture hepatocytes [6]. 
In red blood cells and isolated hepatocytes, the ubiqui- 
tous system L carrier for bulky dipolar amino acids is 
supplemented by a second agency, termed T. This sec- 
ond carrier system is more selective for aromatic amino 
acids, in general having higher affinity for Trp, Tyr and 
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to a lesser extent, Phe. In both cell types, the con;a~bu- 
tion of system T is postulated to play a rote in control- 
ling neuroactive amine biosynthesis when tra.~sport 
across the plasma membrane is the rate-limiting first 
step in metabolism. 
Relatively recent investigations of the lysosomai 
transport of sugars [7], nucleosides [8] and amino acids 
[1,9-12] have largely disproved the view that the diffu- 
sion of solute molecules through pores is the dominant 
means of lysosomal transport (for current reviews see 
Refs. 13, 14). In our labolatories, iysosomal systems 
that mediate amino acid fluxes continue to be dis- 
covered and characterized. Corresponding carrier pro- 
teins of the organellar membrane are analogous with 
those known to exist in the plasma membrane but 
frequently show certain differences. These differences 
are in some cases manifest with regard to less stringent 
requirements on substrate geometry and the apparent 
lack of sensitivity to Na ÷ for transport by the lysosomal 
s)stems [15]. Eight lysosomal transporters have so far 
been implicated in mediation of amino acid flux [13]. 
Hence, there is an increasing awareness of the role 
enacted by lysosomal membrane ca-tiers in the translo- 
cation of httracellutar and intralysosomal metabolic 
products, This awareness logically extends to an interest 
in characterizing the lysosomal transporters relative to 
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analogous plasma membrane transporters by biochem- 
ical and genetic means. 
This report demonstrates two transport systems for 
aromatic and bulky dipolar amino acids in human 
fibroblast lysosomes resembling the T and L carriers 
present in the plasma membrane of human red blood 
ceils and isolated rat hepatocytes. These two systems 
have not been previously discriminated in organellar 
systems, although preliminary findings have been pre- 
sented [16]. This heterogeneity in the handling of bulky 
and aromatic dipolar amino acids by the human 
fibroblast lysosome differs from that observed in rat 
FRTL-5 cell lysosomes. In lysosomes from the FRTL-5 
cell type, one transport system appears to serve for the 
mediation of this class of amino acids [1,17]. Dif- 
ferences between the transport protesting of bulky and 
aromatic dipolar amino acids in lysosomes from the two 
cell types (fibroblast and thyroid) have been discerned 
and are reported in this work. 
E~, ~gerimeataF procedures 
Cell culture and preparation of lysosomal fractions. 
Human fetal skin fibroblasts (GM 0010, Human Genetic 
and Mutant Cell Repository) were grown in 850 cm 2 
roller bottles at 37 °C under atmospheric conditions of 
95% air/57o CO2. Ceils were maintained with Coon's 
modification of Ham's F12 media (Hazelton Researc!: 
Products, Inc.) supplemented with 10% fetal bovine 
serum (Hazelton Research Products, Inc.). Lysosomal 
fractions were isolated on the day of the experiment and 
purified on Percoll density gradients (Pharmacia P-L 
Biochemicals) as described by Pisoni et al. [10]. Fibrob- 
lasts were routinely used before passage 17, as the 
degree of n:)n-saturable uptake appeared to increase 
with increasing cell passage number. The usual resus- 
pension buffer was 100 mM citrate made iso-osmotic 
and buffered with 1 M 'Iris to pH 7.0. 
Lysosomal uptake experiments. Two types of experi- 
ments were performed under different conditions, treat- 
ments or with inhibitor, namely time courses of lyso- 
somal uptake and uptake at fixed time points. For a 
typical time course, a 3H-radiolabdled amino acid (15- 
140 Ci/mmol, Amersham) and the appropriate amount 
of the same unlabelled amino acid in 0.25 M sucrose 
were initially combined with inhibitors or test sub- 
stances to comprise the desired condition. Uptake was 
initiated by adding an equal volume of ice-cold lyso- 
somes in 100 mM citrate/Tris to the pre-warmed radio- 
labelled amino acid mixture. At the selected time points, 
15 ~tl samples were withdrawn and added to 10 ml 
ice-cold PBS, then rapidly filtered through G F / A  glass 
filters (Whatman Paper Ltd.), and washed twice with 
10-ml aliquots of ice-cold buffer. For uptake determina- 
tions at fixed time points, 15 ~1 of radiolabelled-tracer 
amino acid in 0.25 M sucrose was combined with 15 #1 
of inhibitor in 50 mM citrate/Tris/0.125 M sucrose 
(pH 7.0) and warmed in a 37 *C water bath. In kinetic 
experiments, increasing amounts of substate at the 
higher concentrations served as the inhibitor component 
in the incubation mixture. Ice-cold lysosomes in 100 
mM citrate/Tris (15 #1, pH 7.0) were added to begin 
the uptake study. Samples (40 #1) were withdrawn at 
the predetermined time interval, ejected into ice-cold 
PBS and collected on filters as described above. 
Blanks consisted of an equal volume of 100 mM 
citrate/Tris replacing the lysosomal volume in the in- 
cubation mixture. Blanks were processed in the same 
manner as the samples in order to determine the back- 
ground radioactivity retained by the G F / A  filter. This 
vague was subtracted from that of the samples. Zero 
points consisted of radioactivity retained on the filter 
after 7.5 ~! of ice-cold lysosomes were pipetted into 10 
ml cold PBS, followed by 7.5 #1 of radioactive amino 
acid solution into the same tube of PBS, which was then 
filtered and washed twice. Filters were counted for 
radioactivity after adding 10 ml 3aT0b scintillation 
cocktail (Research Products International). 
In order to examine uptake under infinite trans con- 
ditions, iysosomes were first incubated for 30 rain at 
37°C with the methyl ester of either Leu (10 mM) or 
Trp (1 or 10 raM) in 50 mM citrate/Tris/0.125 M 
sucrose, then microfuged for 5 min at 15 600 × g and 
washed twice with 20 mM Mops containing 0.275 M 
mannitol and 1 mg bovine serum albumin/ml before 
final resuspension. A similar wash procedure was fol- 
lowed when lysosomes were pretreated with 0.25 mM 
NEM/50 mM citrate/Tris/0.125 M sucrose for 15 rain 
at 370C in order to study the effect of thiol modifica- 
tion at the membrane on Leu or Trp uptake. 
Latent fl-hexosaminidase activity was determined for 
each lysosomal preparation or treatment condition and 
used to normalize the uptake of amino acid (in pmol) 
per unit of latent activity of this intralysosomal enzyme. 
Because reference of the uptake rate to internal organel- 
lar volume or to protein content has so far been largely 
unobtainable, this method is generally accepted in 
lysosomal transport. It permits comparison of results 
from experiment to experiment as well as among re- 
searchers [7,12,191. 
Statistics and data analysis. The nonsaturable compo- 
nent of amino acid uptake, K d, increased linearly with 
concentration (S) at higher substrate levels. Analysis of 
initial rate data (v) with a FORTRAN program using 
the Gauss-Newton nonlinear least-squares method [19] 
fit the following equation, 
log u = Iog([(Vm~- S) / (  K m + S)] + Kd. S } 
where K m represents the Michaelis-Menten constant 
and Vm~,, the maximum velocity. After subtraction of 
the estimated nonsaturable component from initial up- 
take rate when possible, the data were transformed for 
analysis by both Eadie-Hofstee and double-reciprocal 
plot depictions. 
Standard errors (S.E.) for the percent inhibited up- 
take rate (U++~b) relative to control uptake (U~ ..... ,) 
were calculated using 
lt; 2 . - , 1 / 2  
S.E.( Uiahib/Ueomml ) = (S .L . .Coo I ro  I + ~-E.Tnhib ) / /Uco. t t ,  ol 
Miscellaneous. L-[3H]Tryptophan was received in a 
50% ethanolic solution which was evaporated to dryness 
under N 2 before reconstitutkon and use in aqueous 
incubation mixtures. 
Results and Discussion 
Time courses/driving forces " 
The time courses of Trp and L=.u lysosomal uptake 
are shown in Figs. 1A and lB. Llptake was approxi- 
mately linear through 1 rain for botk compounds. All 
subsequent experiments at fixed tim,,' points used in- 
cubation times of 45 or 60 s to ensure that uptake was 
occurring during the initial, linear portion of the curve. 
The addition of NaC! or MgC1 z + Na2ATP had no 
significant effect on the uptake of either amiqo acid 
although the maximum uptake of Trp appeared to be 
somewhat slower in the presence of Na+; otherwise, the 
curves were superimposable within the error of the 
experiment. 
The pH-dependence of transport is illustrated in Fig. 
2 for both Trp and Leu over the pH range of 5 to 8. 
Leucine uptake steadily accelerates over this pH range, 
increasing from 0.0"/1 pmol/hex per rain at pH 5.2 to 
0.51 pmol/hex per rain at pH 8.0. Tryptophan uptake 
remains constant from pH 5 to 7, then begins to accel- 
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Fig. 2. pH profiles of L-[ ~ H]tryptophan and I..[ ]Hlleucine uptake into 
lysosomes from cultured human fibroblasts. Fibroblast lysosomes 
suspended in 0.3 M sucrose ( 15/xt) were incubat.-d with either 15 ~ti of 
0.03 mM L-I~H1Trp or L-[~HILeu plus 15 /~! of 30 mM Mes (pH 
5-6.5) or M o p  ~p;: 6.5-8) buffers in 0.25 M sucrose tilrated to the 
desired pH with Tris free base. Incubations were performed at 37 °C 
for 45 s. then samples were quenched, lysosomes collected and counted 
for radioactivity. Samples were replicates of three or four separate 
incubations. 
Kinetics 
Characteristically, the rates of entry of Phc, Lcu and 
q rp into the lysosome continued to rise with their 
concentrations. In the millimolar range this rise was 
almost linear to correspond to a large non-saturable 
component of about 5 to 7 pmol Phe/hex per rain per 
mM. This component varied greatly from preparation 
to preparation and experiments in which the non- 
saturable component was unusually large were omitted 
in favor of further replication. Curvilinearity is, how- 
ever, observed in the mieromolar range, as illustrated 
Per Phe in Pig. 3. On the basis of that curvilinearity and 
our estimates of the rate or" non--~=.:;rab!e uptake, we 
have estimated ranges foc possible K,, values. From 
numerous kinetic studies, a consensus K,, range of 
0.005 to 0.015 mM was calculated for Phe, with the 
020 .... 
i = Control A 
0 • MgATP 




i) e ° l  • 
s~ °m ! 
0 B ~ 
Ttrne (rnm) 





,, 010 1 o o o 
@ ° 




Fig, l ,  (Panels A and B) Effect of NaCI and MgATP on the time courses of L-[~Hjtr,jptophan (Panel A) and L-[3H]lcucin¢ (pane! B) uptake into 
Pcrcoll-pudried lysosomcs isolated from cultured human fibroblasts. The ]ysosomes were incubated at 37 °C with either 0.01 mM L-[3HITrp (Pane) 
A) or 0.0l mM L-[3H]Leu (Panel B) in 50 mM citrate/Tris buffer (pH 7.0) containing either (a) 0.125 M sucrose (control), (b) 62,5 mM NaCL or 
(c) 0.125 M sucrose plus 2 mM MgCI 2 and 2 mM Na2ATP. As described in Experimental Procedures, samples wcm withdrawn from the 
incubation medium at the indicated time points, quenched, and the lysosomes then collected on GF/A filters and counted for radioactivity. Time 
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Fig. 3. (Panels A and B) Initial rate kinetics of L-13H]phenylalanine uptake by lysosomes from cultured human fibtoulasts as a function of the 
concentration of phenylalanine, Fibroblasts were incubated for 1 min at 37°C with l--13H]Phe plus nonradiolabelled Phe of :he indicated 
concentration in 50 mM citrate/Tris buffer (pH 7.0) containing 0.125 M sucrose. At the completion of the incubation period the ly~osomes were 
collected and washed, and the amount of [3H]Phe taken up was measured. Incubations were performed in duplicate and tl',e results are 
representative of kinetic experiments repeated three times. The Michaelis. Menten plot of the initial Late of Phc uptake as a function of Phe 
concentration from 0 to 0.1 mM (Panel A). Michaelis-Menten plot of  the initial rate of Phe uptake as a function of Phe concentration from 0.01 to 
20.0 mM (Panel B). The nonsaturable component, K d, has not been subtracted from the data. 
values for Leu and Trp being possibly twice as high. 
Under the conditions of these estimates, simple kinetic 
analysis is rendered unsuitable for distinguishing het- 
eroger.eous transport and hence for identifying a homo- 
gcneous transport route [20]. Therefore, selective inhibi- 
tors were sought which could aid in determining the 
nature of the route(s) serving for the lysosomal passage 
of the large neutral amino acids. 
Inhibition analyses 
T h e  first  i n d i c a t i o n  o f  h e t e r o g e n e i t y  in  the  t r a n s p o r t  
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Fig. 4. Inhibition by b( +)-2-aminobicyclo[2.2.1]heptane.2.carboxytic 
acid of the lysosomal uptake of either L-|3Hlleucine, L-[]H]valine, 
t-[ 3 H]phenylalanine, L-t3 H]tyrosine or L-I 3 H]tryptophan. Lysosomes 
from human fibroblasts were incubated for 45 s at 37°C in either 
0.01 mM 3H-labelled Leu, Vai, Phe, Tyr, or Trp in 50 mM citrate/Tris 
(pH 7.0).'o.125 M sucrose. The BCH concentration was 10 raM. 
Uptake values are the average of two determinations. The experiment 
was performed twice with consistent trends in the inhibition patterns 
although different uptake values attended the two lysosomal prepara- 
tions. Results are shown as a percentage of the control uptake rate 
performed in the absence of inhibitor. For Leu and Val the range of 
inhibition of control was 21 to 35~, while for Phe, Tyr and Trp the 
range was 69 to 80~ of control. Control uptake rates were 0.30 
pmol/hex for Lcu, 0.36 pm~,t/hex for Val, 0.213 pmol/hex for Phe, 
0.268 nmol/hex for Tyr and 0.055 pmol/he× for Trp. 
using BCH in an effort to define the most suitable 
substrate for the lysosomal transporter. In Fig. 4, dis- 
tinct differences between the aromatic and otherwise 
bulky dipolar amino acids are revealed in the pattern of 
inhibition by BCH. The saturable pathway for the bulky 
amino acids, Leu and Val, was almost totally inhibited 
by 10 mM BCH, whereas that of the aromatic amino 
acids, Phe, Tyr and Trp, was decreased by only 25 to 
50% of their control uptake rates. 
To refine the evidence for the role of at least two 
transport systems, the studies were extended to a more 
detailed investigation of inhibitors of Leu uptake using 
numerous analogs (Tables I and I1). In Table I, the 
compounds tested fall into three classes: (1) those s!.-o~:-- 
TABLE I 
Lysosomal L.[ZH]leucine uptake and its inhibition by analogs 
All inhibitor concentrations are 10 mM except [L-Tyr] ffi 0.67 mM and 
[BCO] = 5 mM owing to solubility limitations. Uptake values are the 
mean of :hree determinations with the standard error (S.E.). The 
concentration of L-[3H]leucine was 0.005 raM. Results are expressed 
per unit latent hexosaminidase activity ( 'hex- l ' ) .  
Inhibitor Uptake (mean 4- S.E.) ~ control 
(pmol/hex per rain) 
None 0.13 +0.017 100 
L-Leu 0.016 + 0.004 12 
L-lie 0,021 ± 0,001 16 
L-Val 0.021 + 0.001 16 
L-Met 0.028 :i: O.003 22 
L-Phe 0.032 + 0.001 25 
D-Leu 0,036 + 0.{}04 28 
BCO 0.049 ± 0.005 38 
b( + )~BCH 0.056 + 0.007 43 
L-Trp 0.072 + 0.007 55 
L-Tyr 0.081 =1= 0.007 62 
L-His 0.12 4-0.011 92 
MeAIB 0,12 +0.003 92 
149 
TABLE II 
Lysosomal uptake and inhibition of L-[ ZH]leuch~e 2 
Uptake values are the mean of two determinations with the range in 
parentheses, The concentration of L-[3H]leucine was 0,003 raM. In- 
hibitor concentrations were 10 mM except where indicated otherwise. 
Results are expres.qed per unit latent hexosaminidase activity (' hex - x.~. 
Inhibitor Uptake (range) % control 
(pmol/hex per min) 
None 0.03 (0.003) 100 
L-Leu 0.007 (0.003) 23 
Norleucine 0.005 (0) 17 
B,~,-Dimethylnor- 
leucine (5 mM) 0.006 (0) 20 
Phenylglycine (2 raM) 0.006 (0.001) 20 
b( - )-BCH 0.006 (0.001) 20 
D,L-a-Cyclopropyl- 
a-methylglycine 0.007 (0.001) 23 
3-Methyl-l-amino- 
cyclohexane-t-ear- 
boxylic acid (6,7 raM) 0,008 (0.001) 27 
Cyelopentylamino- 
isobutyric acid (3.3 raM) 0.008 (0.001) 27 
b(+)-BCH 0.01 (0.003) 33 
Cyclopropylglycine 0.012 (0) 40 
lsovaline 0.012 (0.001) 40 
2-Aminobenzonor- 
bomane (3.3 raM) 0.014 (0) 47 
4-Amino-l-methyl- 
piperidine-4-car- 
boxylic acid 0.015 (0.003) 50 
a,a-Dicyelopropyl- 
glycine 0.016 (0.004) 53 
. . . .  
/ 
ing effective inhibition of the saturable pathway(s) (lie, 
Met, Val, Phe, then D-Leu); (2) those showi~ng moderate 
impact in limiting leucine uptake (BCO, b(+)-BCH, 
Trp and Tyr); (3) and those having no demonstrable 
effect on either pathway (His and MeAIB). More specific 
inhibitors of Leu uptake as well as greater knowledge of 
the active site requirements for the substrate were sought 
in the results of Table IL The Leu analogs, norleucine 
(10 mM) and N-dimethylnorleucine (5 mM), fell into 
the class of inhibitors which, within experimental accu- 
racy, eliminated saturable uptake of Leu. It can also be 
seen that the effect of b ( -  )-BCH on Leu uptake differs 
from that of its stereoisomer (b(+)-BCH, as described 
elsewhere [21], in its enhanced effectiveness as an in- 
hibitor, 
A notable characteristic of system T in human red 
blood cells and isolated rat liver cells is affinity of the 
transporter for both L and D isomers of the aromatic 
amino acids. This lack of preference between stereoiso- 
mers was demonstrated for lysosomez by inhibition of 
L-Tyr uptake in Table Ili. The L and D isomers of Phe 
and Trp eliminated the saturable component of Tyr 
transport (as determined by reduction of uptake in the 
presence of an excess of nonradiolabelled Tyr). The 
TABLE II 
Inhibition ~] t-[+H]tyrosme upraise into fibrobtast lysosomes by t_ and o 
isomers of the aromatic amino acid¢ and b v M + )-BCH 
Lysosomes from human fibroblasts were incubated for 1 rain at 37 ~C 
in 0.01 mM L-[~HITyr in 50 mM citrate/Tris (pH 7,0)/0.125 M 
sucrose. The inhibitor concentrations were 5 mM except for L-Tyr 
which was 0.67 raM. Results are expressed as the average uptake of 
triplicate t-l~HlTyr incubations. 
Inhibitor Uptake (mean + S.E.) % control 
(pmol/hex per min) 
None 0.060 + 0.002 100 
I_-Tyr 0.015 + 0.005 25 
L-Phe 0.013 _+ 0.003 22 
o-Phe 0.020 + 0.002 33 
t-Trp O.0l l ± 0.003 18 
D-Trp 0.017 + 0.005 22 
BCH 0.Oat ± 9.~32 52 
dextrorotatory isomer b(+)-BCH was again seen to 
have a lesser inhibitory effect. 
In subsequent experiments, Leu and Norleu were 
selected as model substrate and inhibitor, respectively, 
for the lysosomal system similar to system L of plasma 
membranes, whereas L- and D-Trp served as the model 
substrate and inhibitor for the system similar to T, 
respectively. Table IV depicts the results of an experi- 
ment in which the lysosomal uptake of Leu or L-Trp 
w:,:~ i~,~:asured in the p r e s e n c e  o f  5 r aM n o n r a d i o -  
label led  Leu,  B C H ,  N o r l e u ,  L -Trp  or  D-Trp,  Resu l t s  a re  
e x p r e s s e d  as  the p e r c e n t a g e  o f  Leu  or  T r p  u p t a k e  r a t e  
r e m a i n i n g  w h e n  inh ib i to r  is p r e s e n t  re la t ive  to  the  un in -  
h ib i ted  rate,  I t  c a n  b e  seen tha t  B C H  a n d  N o r l e u  r educe  
[3H]Leu  u p t a k e  to  the s a m e  ex ten t  as does  a d d i n g  
excess  un labe l l ed  Leu  i tself  ( s ign i fy ing  u p t a k e  by  the  
s a t u r a b l e  routes) ,  w h e r e a s  L- a n d  ~ T r p  have  s u b s t a n -  
t ial ly less inhibitory impact. Conversely, D-Trp reduces 
TABLE IV 
Inhibition of L-[JH/tryptophan or t-[~H]leucine uptake into jibroblast 
lysosomes by £-ieucin¢, BCH. norleucine, L-tryptophan or o.tryptophan 
Human fibroblast lysosomes were incubated for 1 rain at 37°C in 
either 0.01 mM L-13HILeu or L-[3Hrl'rp in 50 mM eltrate/Trls (pH 
7.0)/0.125 M sucrose, The inhibitor concentrations were 5 raM, and 
three incubations were performed for each condition. Results are 
expressed as the percentage of control uptak,: with the standard errors 
calculated as described in Experimental Procedures. Control uptakes 
were 0.16 pmol Leu/hex per min and 0.12 pmol Trp/h©x per rain. 
Inhibitor ~g of control ~ of control 
[ 3 H]Leu uptake 13 HITrp uptake 
(mean + S.F..) (mean ::t: S.F_-) 
None 100 + 2.5 100± 1.6 
g- Leu 40 ± 2.8 5 3 + 8.2 
BCH 45 +6.2 63+ ~..9 
Norleu 34 ± 2.8 66 ± 6.2 
L-Trp 56 ± 5.0 43 + 1.8 
D-Trp 60 _+ 2.8 46 4" 8.2 
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Fig. 5. Inhibition of L-[3H]trypto~',han or L-[3H]leucin¢ uptake into 
fibrobiast iysosomes as a [unction of the concentration ~?"~" 
tryptophan. Human fibroblast lysosomes were incubated for I rain at 
37°C in either 0.01 mM ~H-labelled L-Trp or L-Leu in 50 mM 
citrate/Tris (pH 7.0)/'0.125 M sucrose. The inhibited uptake of Trp 
or Leu as a function of D-Trp concentration in the range 0 to 10 mM 
is shown. Each point represents the average of three determinations 
plus and minus ~he standard error. The control uptake rates ~cre 
0.059 pmol/hex for Trp ~nd 0.11 pmol/hex for Leu. 
t-[3HlTrp uptake to the level attainable with excess 
L-Trp whereas Leu, BCH and Norleu do not. Studies to 
determine how the degree of transport inhibition was 
related to inhibitor concentration were then pursued. 
Fig. 5 demonstrates that 0.05 mM D-Trp has an inhibi- 
tory effect on both L-Leu and L-Trp uptake; however, 
on raising the D-Trp inhibitor concentration from 0.05 
to 0.5 raM, the difference in inhibition on the two 
amino acids widens. By 10 mM o-Trp, the uptake of 
L-Trp has been reduced to a~prox. 20% of its original 
value while Leu retains 5070 of its control uptake rate. 
The separate, albeit shared, relationship between the 
substrate/inhibitor pairs for what we provisionally will 
call lysosomal systems t and l is further i|lustrated in 
Figs. 6A and 6B. First L-[3H]Trp (Fig. 6A) and then 
L-[3H]Leu (Fig. 6B) were again used as substrates. Con- 
trol uptake rate and nonsaturable transport rate are 
shown in the first two bars of each plot. in Fig. 6A, it is 
seen that 10 mM Norleu has a greater inhibitory effect 
on L-Trp uptake than does 0.5 mM Norleu, as would be 
expected. The inhibitory effect ef 10 mM Norleu is 
quite comparable to the same concentration of D-Trp; 
however, an additional effect on ~-Trp uptake is seen 
when 0.5 mM Norleu is combined with 10 mM D-Trp. 
Inhibition is not further enhanced when the concentra- 
tion of Norleu is raised to 10 mM; i.e., the additive 
effect is due not to the higher total inhibitor concentra- 
tion but is specific to the presence of two distinct 
inhibitors. In Fig. 6B, neither 0.5 or 10 mM D-Trp have 
an appreciable effect on Leu uptake whereas 10 mM 
Norleu reduces uptake to the nonsaturable level. 
Accordingly, no further effect can arise with addition of 
D-Trp to the saturating concentration of Norleu. 
Trans effects 
In addition to transport bei~g inhibitable to non- 
saturable levels, the phenomenon of trans stimulation 
provides further evidence that carrier-mediated translo- 
cation of substrate is occurring as opposed to binding of 
substrate to the membrane surface without transport. 
Trans stimulation has been a characteristic associated 
with system L in cellular membranes from earliest 
descriptions [22]. In order to load the iysosomal system 
to high internal amino acid concentrations, the highly 
permeant methyl ester of the desired amino acid was 
incubated with the lysosomes. The free amino acid is 
released into the intralysosomai pool as the hydrolysis 
product of the esterase activity which co-purifies in the 
lysosomal fraction during isolate, on. The time course in 
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Fig. 6. (Panels A and B) lnhi-;bilion of L-[3H]ttStptophan (Panel A) or L-|3Hlloucine (Panel B) uptake into fibroblast lysosomes by nofleucine and 
D4ryptophan at different combinations and concentrations of these inhibitors. Human fibroblast lysosomes ~ ~re incubated for 45 s at 37°C in 
either L-[3H]Trp or L-I3H]I.eu, each at 0.01 raM, in 50 mM citrate/Tris (pH 7.0)/0,125 M sucrose. Inhibitor coacentrations and combinations wet0 
0.5 mM and/or  I0 raM. (Panel A) L-Trp uptake. (Panel B) L-Lcu uptake. Uptake values represent the mean of three determinations per condition 
plus the standard error. Nonsat, non-saturable component of uptake', n L  norleu. 
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Fig. 7. (Panels A and B) Effect of trans conditions on the uptake of t-{ 3 H]leucine or L-I 3HItryptophan by fibroblast fysosomes. Percoll-purified 
lysosomes were loaded with L-Leu methyl ester (LME, Panel A) or L-Trp methyl ester (TME, Panel B) as described in Experimental Procedures. 
(Panel A) LME-loaded and nonloaded lysosomes were incubated at 37°C in 0.005 mM L-[3HILeu in 50 mM citrate/Tfis (pH 7.0)/0.125 M 
sucrose. (Panel B) TME-Ioaded and nontoaded ly,;osomes were incubated at 37 °C in 0.0l mM L-! 3 HITrp in 50 mM citrate/Trig (pH 7.0)/0.125 M 
sucrose. The concentration of n-Trp in Panel B was 5 raM. Aliquots were removed from the incubation mixtures at the indicated times and 
lysosomes collected, washed and counted as described in Experimental Procedures. 
Fig. 7A shows that preloaded Leu increases the uptake 
of Leu by a factor of 2 to 3, consistent with the 
carrier-mediated process identified with system L sub- 
mates ,  Loading lysosomes by incubation with 1 mM 
L-Tip methyl ester for 30 rain increases the subsequent 
uptake of L-Trp by 1.5-2.5-fold of  the control, as shown 
in Fig. 7B. Inhibition of uptake into preloaded lyso- 
somes by D-Trp (5 mM) reduces transport to rates 
below those of the control rate (namely, L-Trp uptake 
into lysosomes under  zero trans conditions), but not to 
the same extent that o-Tip  inhibits L-Tip uptake into 
control  iysosomes; hence, trans stimulation appears to 
be a factor in both lysosomal pathways. 
N E M  
The results of the uptake of radiolabelled Leu, Val, 
Trp and Phe after treatment of the lysosomal fraction 
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mide on uptake of 3H-labelled L-leueine, t-valine, L-tryptophan or 
L-phenylalanine. Percoll-purified human lysosomes were treated with 
0.25 mM NEM as described in Experimental Procedures. NEM-treated 
and untreated lysosomes were then incubated for 45 s at 37°C in 
either 0.01 mM 3H-labdlcd Leu, Val, Trp or Ph¢ in 50 mM citrate/Tris 
(pH 7.0)/0.125 M sucrose. The inhibitor concentration for determina- 
tion of the non-saturable component was l0 raM. The mean value of 
three uptake determinations per condition are shown plus the stan- 
dard error. $, percent of control uptake rate for NEM-treated lyso- 
sprees; ND, not determined. 
with 0.25 mM N EM are shown in Fig. 8. The non- 
saturable component  wa~ d . . . . . . . .  :.eL for the first three 
of these four amino acids and was low in each case, 
while totai uptake t, nder control conditions was rela- 
tively high. NEM moderately inhibited the mediated 
transport of Leu and Val (a reduction of 38 to 46% 
from total control uptake), two amino acids we classify 
as substrates favored by lysosomal system I: notwith- 
standing, NEM largely eliminated the saturable uptake 
of substrates favored by lysosomal system, t, namely 
L-Trp and Phe (reduction to 72 to 74% of total control 
rates). This distinction appears quite clear between 
routes for the bulky versus the aromatic sttbstrates; 
however, it tnust be emphasized that the reproducibility 
of this experimen: was sensitive to variability in the 
magnitudes of total uptake and its nonsaturable compo- 
nent. These are effects which we have already associated 
with the approach to contiguity of the fibroblasts in 
culture. 
Additional discussion 
The ATP-driven proton pump of the lysosomal mem- 
brane maintains an outwardly directed H* gradient in 
vivo, resulting in an intralysosomal pH of approxi- 
mately 5 [23-25]. The role of this gradient as a driving 
force in iysosomal accumulation of weak bases is a 
acidotropic phenomenon [26], which is distinct from 
active or cotransport processes. In order to regenerate 
the irH gradient in freshly isolated lysosomes, ATP was 
added to the incubation media. No  significant effect on 
the uptake of Trp and Leu was observed under these 
conditions, implying independence from the outwardly 
directed H + gradient. As would be expected, differences 
in lysosomal efflux and influx in the presence of ATP 
have been seen for amino acids of net charge, Arg [11] 
and Lys [9], and for cystine [12], but not for the 
zwitterionic Pro [10]. Changing the pH of the incuba- 
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tion medium over the range of pH 5 to 8 increased the 
uptake rate of Leu substantially while Trp uptake did 
not increase until approximately pH 7. The change in 
ionization state for these amino acids is less than 1~o 
over this pH range. Along with the lack of ATP require- 
ment, this result suggests that it is the transporter 
molecule that is sensitive to pH changes. Such does not 
appear to be the case in human or pigeon red blood cell 
transport of Trp and [eu [3] or in human placental 
brush-border vesicle uptake of Trp [27] where only a 
very slight downward or no effect at all on rate is see~ 
with rising pH. Mitsumeto et ai. [28] have reported 
stimulation of Leu uptake by plasma membmn~ vesicles 
from Chang liver cells in,the presence of an inwardly 
directed H + gradient. As with other amino acids thus 
far studied, Leu and Trp also fail to show a requirement 
for Na + in the extralysosomal medium. 
Several lines of evidence support the duality in lyso- 
somal transport of bulky and aromatic dipolar amino 
acids; nonetheless, clear discrimination between the two 
systems, as has been accomplished with the apparently 
z, nalogous plasma membrane carriers using BCH and 
D.Trp, has been more difficult than usual in the lyso- 
spinal system. For instance, it was not possible to 
differentiate the shared carrier systems with simple one- 
or two-component kinetic plots as has been done with 
isolated rat hepatocytes using BCH [5]. This difficulty 
appeared to arise in part from the greater overlap of 
amino acid affinities in the lysosomal transport process, 
further complicated by larger experimental variance. 
The kinetics were well described by a model involving 
transport by a single carrier site. K m values for each of 
the substrates were in the range of 0.005-0.02 raM. The 
similarity in the magnitudes of the K m values possibly 
explain the inability of the simplest kinetic modeling to 
discriminate the two transport components, now recog- 
nized as a frequent problem [29]. 
The component of lysosomal Ala transport inhibita- 
ble by Leu and provisionally designated e [10] should 
also be considered as possibly contributing to the het- 
erogeneity observed here for the transport of branched- 
chain amino acids. Component e serves as a major 
route for lysosomal transport of Ata, Ser and Thr, but 
Leu transport by system e may be considered possible. 
Accordingly, the relation between the components des- 
ignzted e and l remains to be established as to overlap 
or even conceivable identity. 
Several criteria for defining parallel lysosomal trans- 
port systems similar to the T and L dichotomy in the 
plasma membrane were examined by inhibition analyses. 
The tests were conducted to obtain information with 
respect to binding site requirements and specificity. 
Leucine uptake was inhibited by a number of analogs 
which have previously been shown to compete for the 
system L carrier [21,30]. Tolerance, if not preference, 
for bulky side-chains in the form of structures such as 
the norbornane ring which bears a planar extension in 
aminobenzonorbornane and 4-amino-l-methyl-piperi- 
dinc-4-carboxylic acid, and also for dicyclopropylgly- 
cine was observed [31]. This finding may imply a less 
rigorous structural requirement at the binding site, 
parallel to that observed in the lysosomal transport of 
the dicarboxylic acids [15]. Norlcueine inhibition of Leu 
uptake appeared more specific than that by BCH, used 
classically as a system L inhibitor. A distinguishing 
anomaly of system .T.---',a red blood cells and isolated 
hepatocytes is its affinity for the D isomers of the 
aromatic amino acids, in particular, D-Trp. Contention 
exists as to whether or not E,-Trp is actually trans- 
located in those cells and if so, whether this occurs by a 
saturable pro~ess; the consensus, however, holds that 
D-Trp interaction with the T carrier is competitive [4,5]. 
In the lysosomal system, D-Trp was an effective inhibi- 
tor of L-Trp uptake. "[he impact of o-Trp inhibition on 
Leu uptake was suggestive of the extent of system 
t-contribution to Leu uptake (Figs. 6A and 6B). This 
result is in contrast to that obtained by Bernar et al. [1], 
where D-Tyr only marginally inhibited the uptake of 
L-Tyr into lysosomes from FRTL-5 thyroid cells. Tyro- 
sine and Trp have similar affinities for system T where 
it is present [2], so this discrepancy between results may 
be due to the different origins of the lysosomal fractions 
used (human fibroblasts versus rat thyroid FRTL-5 
cells). 
The clearest difference between the transport proc- 
essing of the two groups of amino acids was seen when 
lysosomal fractions were prctreated with the 
sulfhydryl-reactive agent, N-ethylmaleimide, at 0.25 
raM. Although NEM is known to interact with the 
lysosomal H+-ATPase pump [25], it can be construed 
from our earlier discussion that this would not have a 
direct effect on the transport of these amino acids, It 
appears that NEM preferentially inactivates the carrier 
responsible for the major part of Trp and Phe uptake. 
This finding is consistent with the behavior observed in 
human red blood cells [3] but not in lysosomes isolated 
from rat thyroid cells [1]. Chiles et al. [32] have reported 
a lack of NEM sensitivity for amino acid transporters in 
four hepatoma cell lines as an apparent characteristic of 
the cell transformation. This generalization may par- 
tially explain the lack of a NEM effect in continuously 
cultured FRTL-5 cells; the human fibroblasts used in 
these experiments can be subcultured a finite number of 
times and are not considered transformed. Again, the 
disparity between the two lysosomal systems may be 
best explained in terms of cellular origin. 
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